Functionalising antibiotics with nitroxides as an effective broad-spectrum biofilm eradication strategy.

Anthony Verderosa,Kathryn Fairfull-Smith,Makrina Totsika

doi:10.5194/biofilms9-12

Abstract

&lt;p&gt;&lt;strong&gt;Background:&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;The adhesion of planktonic bacteria to a surface (biotic or abiotic), and their subsequent ability to aggregate into multicellular communities called biofilms, is a major driving force of failing antibiotic therapy and persistence in chronic infections caused by a variety of pathogens (e.g., &lt;em&gt;Pseudomonas aeruginosa&lt;/em&gt;, &lt;em&gt;Escherichia coli&lt;/em&gt;, and &lt;em&gt;Staphylococcus aureus)&lt;/em&gt;&amp;#160;and plaguing healthcare systems worldwide. Biofilms are estimated to be involved in over 80% of all microbial infections in humans, and commonly exhibit extreme resistance to conventional antimicrobial treatments. Consequently, there is an urgent need for novel antimicrobial agents, which target biofilm residing cells. Here, we present the development and evaluation of a new generation of dual-acting nitroxide functionalised antibiotics with potent biofilm eradication activity.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Methodology:&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;Synthetic organic chemistry was utilised to produce a new generation of nitroxide functionalised antibiotics with targeted biofilm eradication capabilities. These compounds were tested for biofilm eradication and/or dispersal of several bacterial species using the MBEC&lt;sup&gt;TM&lt;/sup&gt; device, a reproducible high-throughput static biofilm formation system. Mature biofilms were treated with serial dilutions of the specific test agent(s) and recovered bacterial numbers were quantified by absorbance spectroscopy at 600 nm or plating for viable cell counts. Treated biofilms were also stained with Live/Dead (SYTO-9/PI) bacterial viability kit and analysed by fluorescence and confocal laser scanning microscopy.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;&lt;/p&gt; &lt;p&gt;Nitroxide functionalised antibiotics exhibit potent biofilm-eradication activity against a variety of medically important pathogens, including &lt;em&gt;P. aeruginosa&lt;/em&gt;, uropathogenic &lt;em&gt;E. coli&lt;/em&gt;, and &lt;em&gt;S. aureus&lt;/em&gt;. In Minimal Biofilm Eradication Concentration (MBEC) assays nitroxide functionalised antibiotics were 64-fold more potent against &lt;em&gt;S. aureus&lt;/em&gt; biofilms, and at least 2-fold more potent against uropathogenic &lt;em&gt;E. coli&lt;/em&gt; biofilms than the parent antibiotic ciprofloxacin.&lt;/p&gt; &lt;p&gt;&lt;strong&gt;Conclusions:&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;Currently, antibiotics are often entirely ineffective against biofilm infections. Nitroxide functionalised antibiotics represent a promising new strategy, which could circumvent the resistance of Gram-positive and Gram-negative biofilms to conventional treatments.&lt;/p&gt;

Full Text